期刊
JOURNAL OF INFECTIOUS DISEASES
卷 194, 期 8, 页码 1135-1140出版社
UNIV CHICAGO PRESS
DOI: 10.1086/507705
关键词
-
资金
- NIAID NIH HHS [K08 AI059072] Funding Source: Medline
- NIDDK NIH HHS [R01 DK59010] Funding Source: Medline
Fabry disease is an X-linked recessive disorder in which affected persons lack alpha-galactosidase A (alpha- GalA), which leads to excess glycosphingolipids in tissues, mainly globotriaosylceramide (Gb3). Gb3 is the cellular receptor for Shiga toxin (Stx), the primary virulence factor of enterohemorrhagic Escherichia coli. alpha-GalA-knockout mice were significantly protected against lethal intraperitoneal doses of Stx2 or oral doses of Stx2-expressing bacteria, compared with wild-type (wt) control mice. Kidneys of moribund wt mice revealed tubular necrosis, but no histopathologic changes were observed in Gb3-overexpressing mice. Reducing Gb3 levels in alpha-GalA-knockout mice by the intravenous injection of recombinant human a- GalA restored the susceptibility of knockout mice to lethal doses of Stx2. These results suggest that excess amounts of Gb3 in alpha-GalA-deficient mice may impair toxin delivery to susceptible tissues.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据